Outlook Therapeutics, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-36.2% -$4M
$-15M
Free Cash Flow↓-36.2% -$4M
$-15M
Investing Cash Flow
—
Financing Cash Flow↑+791.5% +$14M
$16M
Capex
—
Stock-Based Comp↓-76.0% -$3M
$881K
Debt Issued
$0
Debt Repaid
$2M
D&A↑+4.4% +$1K
$30K
SBC Allocated Expense↓-76.0% -$3M
$881K